Skip to main content

Table 1 Clinical characteristics and treatment outcomes of our patients

From: Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations

Patient Case 1 Case 2 Case 3 Case 4 Case 5
Type of OMD Jaw Opening Jaw Opening Jaw Closure Jaw Opening Jaw Opening
Etiology Idiopathic Idiopathic Idiopathic Idiopathic Tardive
Age 58 48 32 57 50
Gender Male Female Male Female Female
Duration 5y 1y 2y 10y 1y
Follow-up 3y 2y 1.5y 8y 1y
Other Dystonia No Blepharospasm No No No
Orofaciolingual involvement No Tongue protrusion No Tongue dyskinesias, bruxism Facial grimacing, tongue dyskinesia, lip biting
Botulinum toxin/sessions Yes/9 Yes/4 Yes/4 Yes/1 Yes/2
Site(s) Lateral pterygoids 75 u/side Lateral pterygoids 50 u/side Masseters 50 u/side Lateral pterygoids 25 u/side Lateral. pterygoids
Total 150 100 100 50 N/A
Response (GIS) to Botulinum toxin A injections Marked No Moderate No No
Duration of response 3 months ---- 3 months ----- ----
Antidystonic medications (response) No trihexyphenidyl lorazepam, tetrabenazine, (marked) No tetrabenazine, gabapentine (marked) No
Weight loss No 15 lbs no 15 lbs 13 lbs
Weight gain after treatment ----- 15 lbs ----- 10 lbs N/A